These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2428880)
21. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000 [TBL] [Abstract][Full Text] [Related]
22. Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG. Yang L; Cen J; Xue Q; Li J; Bi Y; Sun L; Liu W Virus Res; 2013 Jun; 174(1-2):47-51. PubMed ID: 23499997 [TBL] [Abstract][Full Text] [Related]
23. Purification of envelope glycoproteins of human T cell lymphotropic virus type I (HTLV-I) by affinity chromatography. Palker TJ; Clark ME; Sarngadharan MG; Matthews TJ J Virol Methods; 1987 Dec; 18(4):243-55. PubMed ID: 2832431 [TBL] [Abstract][Full Text] [Related]
24. Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein. Wang JJ; Steel S; Wisniewolski R; Wang CY Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6159-63. PubMed ID: 2426711 [TBL] [Abstract][Full Text] [Related]
25. [Synthesis of peptides of the preS1-region of the viral hepatitis B envelope protein and localization of antigenic determinants]. Prokuronova EI; Khlebnikova IN; Zheltukhina GA; Evstigneeva RP; Semiletov IuA; Karpova VA; Kalinina TI; Khudiakov IuE; Pavliuchenkova RP; Smirnov VD Bioorg Khim; 1991 Nov; 17(11):1500-9. PubMed ID: 1725845 [TBL] [Abstract][Full Text] [Related]
26. Production of virus-specific antisera using synthetic peptides corresponding to sequences in the yellow fever E protein: brief report. Jackson RE; Phillpotts RJ Viral Immunol; 1997; 10(1):11-4. PubMed ID: 9095527 [TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659 [TBL] [Abstract][Full Text] [Related]
28. Immunogenicity of peptides cleaved by cyanogen bromide from Japanese encephalitis virus envelope glycoprotein E. Srivastava AK; Morita K; Igarashi A Acta Virol; 1990 May; 34(3):228-38. PubMed ID: 1980396 [TBL] [Abstract][Full Text] [Related]
29. Virus neutralizing and enhancing epitopes characterized by synthetic oligopeptides derived from the feline leukaemia virus glycoprotein sequence. Nick S; Klaws J; Friebel K; Birr C; Hunsmann G; Bayer H J Gen Virol; 1990 Jan; 71 ( Pt 1)():77-83. PubMed ID: 1689371 [TBL] [Abstract][Full Text] [Related]
30. A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I. Lal RB; Rudolph DL; Palker TJ; Coligan JE; Folks TM J Gen Virol; 1991 Sep; 72 ( Pt 9)():2321-4. PubMed ID: 1716657 [TBL] [Abstract][Full Text] [Related]
31. Production and characterization of antibodies to mouse scrapie-amyloid protein elicited by non-carrier linked synthetic peptide immunogens. Di Martino A; Bigon E; Corona G; Callegaro L J Mol Recognit; 1991; 4(2-3):85-91. PubMed ID: 1687353 [TBL] [Abstract][Full Text] [Related]
32. [Synthesis and immunological properties of the peptide fragment of the hepatitis B virus envelope preS-protein]. Evstigneeva RP; Zheltukhina GA; Prokuronova EI; Smirnov VD; Semiletov IuA; Kalinina TI; Khudiakov IuE; Khromov IS; Favorov MO; Iashina TL Bioorg Khim; 1990 Jan; 16(1):34-40. PubMed ID: 1693272 [TBL] [Abstract][Full Text] [Related]
33. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Allan JS; Coligan JE; Barin F; McLane MF; Sodroski JG; Rosen CA; Haseltine WA; Lee TH; Essex M Science; 1985 May; 228(4703):1091-4. PubMed ID: 2986290 [TBL] [Abstract][Full Text] [Related]
34. Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein. Schüpbach J; Sarngadharan MG; Gallo RC Science; 1984 May; 224(4649):607-10. PubMed ID: 6324349 [TBL] [Abstract][Full Text] [Related]
35. Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus. Strynadka NC; Redmond MJ; Parker JM; Scraba DG; Hodges RS J Virol; 1988 Sep; 62(9):3474-83. PubMed ID: 2457115 [TBL] [Abstract][Full Text] [Related]
36. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. Krasko AG; Moshnikova AB; Kozhich AT; Tchikin LD; Ivanov VT; Vladyko AS; Lukashevich IS Arch Virol; 1990; 115(1-2):133-7. PubMed ID: 1701079 [TBL] [Abstract][Full Text] [Related]
37. Serological characterization of human T-cell leukemia (lymphotropic) virus, type I (HTLV-I) small envelope protein. Newman MJ; Baker IT; Reitz MS; Eiden M; Blattner WA; Gallo RC; Mann DL Virology; 1986 Apr; 150(1):106-16. PubMed ID: 3006330 [TBL] [Abstract][Full Text] [Related]
38. Characterization of immune response to synthetic peptides derived from the hemagglutinin of measles virus. Meqdam M; Mostratos A New Microbiol; 2000 Apr; 23(2):113-8. PubMed ID: 10872680 [TBL] [Abstract][Full Text] [Related]